Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on September 22, 2005

Stroke. 2005
Published online before print September 22, 2005, doi: 10.1161/01.STR.0000182256.32489.99
A more recent version of this article appeared on October 1, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
36/10/2148    most recent
01.STR.0000182256.32489.99v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuroda, S.
Right arrow Articles by Iwasaki, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuroda, S.
Right arrow Articles by Iwasaki, Y.
Related Collections
Right arrow Primary and Secondary Stroke Prevention
Right arrow Stroke in Children and the Young

Submitted on May 9, 2005
Accepted on June 2, 2005

Incidence and Clinical Features of Disease Progression in Adult Moyamoya Disease

Satoshi Kuroda MD, PhD*; Tatsuya Ishikawa MD, PhD; Kiyohiro Houkin MD, PhD; Rina Nanba MD, PhD; Masaaki Hokari MD, PhD; and Yoshinobu Iwasaki MD, PhD

From the Department of Neurosurgery (S.K., T.I., R.N., M.H., Y.I.), Hokkaido University Graduate School of Medicine; and the Department of Neurosurgery (K.H.), Sapporo Medical University, Sapporo, Japan

* To whom correspondence should be addressed. E-mail: skuroda{at}med.hokudai.ac.jp.

Background and Purpose--The progression of occlusive lesions in the major intracranial arteries was believed to be very rare in adult patients with moyamoya disease. The present study aims to clarify the incidence and clinical features of disease progression in adult moyamoya disease.

Methods--For the past 15 years, 120 adult Japanese patients were diagnosed with moyamoya disease. Of these, 63 patients were enrolled in this historical prospective cohort study on a total of 86 nonoperated hemispheres. All were followed up with a mean period of 73.6 months. MRI and magnetic resonance angiography were repeated every 6 to 12 months, and cerebral angiography was performed when disease progression was suspected on MRI and magnetic resonance angiography.

Results--Disease progression occurred in 15 of 86 nonoperated hemispheres (17.4% per hemisphere) or in 15 of 63 patients (23.8% per patient) during the follow-up period. Occlusive arterial lesions progressed in both anterior and posterior circulations, in both symptomatic and asymptomatic patients, and in both bilateral and unilateral types. Eight of 15 patients developed ischemic or hemorrhagic events in relation to disease progression. Multivariate analysis revealed that the odds ratio conferred by a male patient was 0.20 (95% CI, 0.04 to 0.97).

Conclusions--The incidence of disease progression in adult moyamoya disease is much higher than recognized before, and female patients may be at higher risk for it than male patients. Careful follow-up would be essential to prevent additional stroke occurrence in medically treated adult patients with moyamoya disease, even if they are asymptomatic or are diagnosed as having unilateral moyamoya disease.


Key words: adult • cerebral ischemia • disease progression • moyamoya disease




This article has been cited by other articles:


Home page
NEJMHome page
R. M. Scott and E. R. Smith
Moyamoya Disease and Moyamoya Syndrome
N. Engl. J. Med., March 19, 2009; 360(12): 1226 - 1237.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
J-M Kim, S-H Lee, and J-K Roh
Changing ischaemic lesion patterns in adult moyamoya disease
J. Neurol. Neurosurg. Psychiatry, January 1, 2009; 80(1): 36 - 40.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. F. Meschia and O. A. Ross
Heterogeneity of Moyamoya disease: After a decade of linkage, is there new hope for a gene?
Neurology, June 10, 2008; 70(24_Part_2): 2353 - 2354.
[Full Text] [PDF]


Home page
StrokeHome page
S. Kuriyama, Y. Kusaka, M. Fujimura, K. Wakai, A. Tamakoshi, S. Hashimoto, I. Tsuji, Y. Inaba, and T. Yoshimoto
Prevalence and Clinicoepidemiological Features of Moyamoya Disease in Japan: Findings From a Nationwide Epidemiological Survey
Stroke, January 1, 2008; 39(1): 42 - 47.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. Kuroda, N. Hashimoto, T. Yoshimoto, Y. Iwasaki, and for the Research Committee on Moyamoya Disease in
Radiological Findings, Clinical Course, and Outcome in Asymptomatic Moyamoya Disease: Results of Multicenter Survey in Japan
Stroke, May 1, 2007; 38(5): 1430 - 1435.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C. L. Hallemeier, K. M. Rich, R. L. Grubb Jr, M. R. Chicoine, C. J. Moran, D. T. Cross III, G. J. Zipfel, R. G. Dacey Jr, and C. P. Derdeyn
Clinical Features and Outcome in North American Adults With Moyamoya Phenomenon
Stroke, June 1, 2006; 37(6): 1490 - 1496.
[Abstract] [Full Text] [PDF]